Cancer of unknown primary origin future or investigational therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Roukoz A. Karam, M.D.[2]
Overview
Overview
Future or Investigational Therapies
Future or Investigational Therapies
Current research involves the application of proteomic and genomic tools to unknown primary cancer.
References
References
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH